The new melanoma markers: MART-1 and Melan-A (the NIH experience)
D000310:Adrenal Gland Neoplasms / Q000473:pathology; D000951:Antigens, Neoplasm / Q000378:metabolism*; D014408:Biomarkers, Tumor / Q000378:metabolism*; D019496:Cancer Vaccines / Q000008:administration & dosage; D015789:HLA-A2 Antigen / Q000378:metabolism; D006801:Humans; D007124:Immunoenzyme Techniques; D058965:MART-1 Antigen; D008545:Melanoma / Q000201:enzymology / Q000276:immunology / Q000473:pathology* / Q000628:therapy; D008562:Membrane Glycoproteins / Q000378:metabolism; D014442:Monophenol Monooxygenase / Q000378:metabolism; D009316:National Institutes of Health (U.S.); D009363:Neoplasm Proteins / Q000378:metabolism*; D014481:United States; D058951:gp100 Melanoma Antigen